HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

zanolimumab

a human monoclonal antibody targeted against CD4 for the potential treatment of cutaneous and noncutaneous T-cell lymphomas
Networked: 11 relevant articles (3 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Prous, J R: 3 articles (04/2006 - 06/2005)
2. Rabasseda, X: 3 articles (04/2006 - 06/2005)
3. Osterborg, Anders: 2 articles (09/2010 - 06/2007)
4. Sterry, Wolfram: 2 articles (12/2008 - 04/2007)
5. Assaf, Chalid: 2 articles (12/2008 - 04/2007)
6. Parren, Paul W H I: 2 articles (10/2008 - 10/2007)
7. Baadsgaard, Ole: 2 articles (10/2007 - 06/2007)
8. Bayés, M: 2 articles (01/2006 - 06/2005)
9. Illidge, Tim M: 1 article (05/2011)
10. Brown, Nick: 1 article (05/2011)

Related Diseases

1. T-Cell Lymphoma (Lymphoma, T Cell)
2. Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
3. Neoplasms (Cancer)
4. Lymphoma (Lymphomas)
5. Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)

Related Drugs and Biologics

1. ofatumumab
2. Epidermal Growth Factor Receptor (EGF Receptor)
3. Hepatitis B e Antigens
4. Monoclonal Antibodies
5. cAC10-vcMMAE
6. zalutumumab
7. Sodium
8. Insulin (Novolin)
9. vildagliptin
10. efalizumab

Related Therapies and Procedures

1. Therapeutics
2. Intravenous Infusions
3. Heterologous Transplantation (Xenotransplantation)